While it’s often suggested that women with dense breasts get ultrasound or other extra screenings after a mammogram, a new…
Read More
FDA approves Pfizer’s high profile breast cancer drug
The U.S. Food and Drug Administration on Tuesday approved Pfizer Inc’s Ibrance, a potential new standard of care for advanced…
Read More
Hormone-blocker slashes breast cancer risk, study shows
Women at high risk of developing breast cancer because of family history or bad genes have a new option to…
Read More
Early ovary removal may reduce cancer risk, study says
For women who carry a notorious cancer gene, surgery to remove healthy ovaries is one of the most protective steps…
Read MoreWith gene mutations, second breast cancer risk rises over time
Women who are genetically susceptible to breast cancer and develop it in one breast are at higher than average risk…
Read More
Atypical hyperplasia bigger breast cancer risk factor than previously thought, study says
Women with atypical hyperplasia of the breast have a 1 percent increased risk of developing breast cancer each year, suggests…
Read More
